7 drug(s) with this reaction
1,276 total reports
Inappropriate Schedule Of Drug Administration has been reported as an adverse reaction across 7 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,276 adverse event reports mention inappropriate schedule of drug administration in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with inappropriate schedule of drug administration, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have inappropriate schedule of drug administration listed in their FDA adverse event reports, sorted by report count:
In addition to inappropriate schedule of drug administration, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
7 drug(s) manufactured by Haleon Us Holdings Llc have inappropriate schedule of drug administration listed in their FDA adverse event reports: DOCOSANOL, GLYCERIN, LIDOCAINE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE, ACETAMINOPHEN, CAFFEINE, and others.
There are a combined 1,276 reports of inappropriate schedule of drug administration across 7 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.